Abstract:Context: Preventing posttraumatic stress disorder (PTSD) is a pressing public health need. Objectives: To compare early and delayed exposure-based, cognitive, and pharmacological interventions for preventing PTSD. Design: Equipoise-stratified randomized controlled study. Setting: Hadassah Hospital unselectively receives trauma survivors from Jerusalem and vicinity. Participants: Consecutively admitted survivors of traumatic events were assessed by use of structured telephone interviews a mean (SD) 9.61 (3.91) days after the traumatic event. Survivors with symptoms of acute stress disorder were referred for clinical assessment. Survivors who met PTSD symptom criteria during the clinical assessment were invited to receive treatment. Interventions: Twelve weekly sessions of prolonged exposure (PE; n = 63), or cognitive therapy (CT; n = 40), or double blind treatment with 2 daily tablets of either escitalopram (10 mg) or placebo (selective serotonin reuptake inhibitor/placebo; n = 46), or 12 weeks in a waiting list group (n = 93). Treatment started a mean (SD) 29.8 (5.7) days after the traumatic event. Waiting list participants with PTSD after 12 weeks received PE a mean (SD) 151.8 (42.4) days after the traumatic event (delayed PE). Main outcome measure: Proportion of participants with PTSD after treatment, as determined by the use of the Clinician-Administered PTSD Scale (CAPS) 5 and 9 months after the traumatic event. Treatment assignment and attendance were concealed from the clinicians who used the CAPS. Results: At 5 months, 21.6% of participants who received PE and 57.1% of comparable participants on the waiting list had PTSD (odds ratio [OR], 0.21 [95% CI, 0.09-0.46]). At 5 months, 20.0% of participants who received CT and 58.7% of comparable participants on the waiting list had PTSD (OR, 0.18 [CI, 0.06-0.48]). The PE group did not differ from the CT group with regard to PTSD outcome (OR, 0.87 [95% CI, 0.29-2.62]). The PTSD prevalence rates did not differ between the escitalopram and placebo subgroups (61.9% vs 55.6%; OR, 0.77 [95% CI, 0.21-2.77]). At 9 months, 20.8% of participants who received PE and 21.4% of participants on the waiting list had PTSD (OR, 1.04 [95% CI, 0.40-2.67]). Participants with partial PTSD before treatment onset did similarly well with and without treatment. Conclusions: Prolonged exposure, CT, and delayed PE effectively prevent chronic PTSD in recent survivors. The lack of improvement from treatment with escitalopram requires further evaluation. Trauma-focused clinical interventions have no added benefit to survivors with subthreshold PTSD symptoms. Trial Registration clinicaltrials.gov Identifier: NCT00146900.

Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial

A brief behavioural treatment of chronic post-traumatic stress disorder in earthquake survivors: results from an open clinical trial

A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator

Single-case experimental studies of a self-help manual for traumatic stress in earthquake survivors

Enhancing recovery in post-earthquake adolescents: examining the impact of a psychoeducational intervention on traumatic stress symptoms and coping strategies

Teacher-mediated intervention after disaster: a controlled three-year follow-up of children's functioning

A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake

Psychological Impact of Disaster Relief Operations: A Study Following Consecutive Earthquakes in Turkey

TF-CBT for Child Earthquake Survivors: Promoting Self-Compassion, PTG, and Reducing Behavioral Problems

EMDR versus waiting list in individuals at clinical high risk for psychosis with post-traumatic stress symptoms: A randomized controlled trial

Investigation of optimal dose of early intervention to prevent posttraumatic stress disorder: A multiarm randomized trial of one and three sessions of modified prolonged exposure

Prevention of posttraumatic stress disorder by early treatment: results from the Jerusalem Trauma Outreach And Prevention study

Shattered ground, resilient souls: examining coping strategies, social support, and earthquake exposure's effects on post-traumatic stress disorder symptoms among adolescent and young adults survivors of the 2023 earthquake in Türkiye

Survey of cognitive-behavioral therapy for orphans with post-traumatic stress disorder following Wenchuan earthquake

Efficacy of two brief trauma-focussed writing interventions in comparison to positive experiences writing: A randomized controlled trial

Behavioral activation is associated with post-disaster mental health: Secondary longitudinal analysis from a population-based study

Well‐Being Therapy as Rehabilitation Therapy for Posttraumatic Stress Disorder Symptoms: A Randomized Controlled Trial

Correlates of Posttraumatic Stress Disorder in the Aftermath of the February 2023 Earthquake in Turkey

Visual Schema Displacement Therapy versus Eye Movement Desensitization and Reprocessing therapy versus waitlist in the treatment of post-traumatic stress disorder: results of a randomized clinical trial

Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study

Open Trial of a Brief Imagery-Based Stabilization Psychotherapy for Adults with Acute Posttraumatic Stress Disorder